Braeburn Pharmaceuticals
PA - Plymouth MeetingPharmaceutical
Focus: Braeburn Pharmaceuticals is a specialty pharmaceutical company headquartered in Plymouth Meeting, PA, focused on out-licensing models in neurology with a concentrated revenue base from a single marketed product.
Profile data last refreshed 9h ago · AI intelligence enriched 1w ago
Open Jobs
7+1 this month
Stable — net +1 jobs in 30d
5 added, 4 removed. Backfill posture.
Should You Work at Braeburn Pharmaceuticals?
AI assessmentBraeburn offers product stability and meaningful pipeline potential, but extreme revenue concentration and minimal hiring scale make this a niche opportunity suited for mission-driven candidates in addiction medicine rather than those seeking rapid career scaling.
Why Work Here
- BRIXADI is at peak lifecycle with LOE protection until 2032, providing stable revenue and product momentum.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$363K Part DStable
Peak6.0yr
Sole revenue-generating product, representing 100% of company revenue, with 8+ years of patent protection remaining.
Help build intelligence for Braeburn Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.